$464.99
Last update: Nov 3, 5:02 AM
Amgen Inc
AMGNNASDAQ
Amgen (AMGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Amgen (AMGN) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $22.3 - $23.5, compared to a consensus EPS estimate of $22.39. Amgen also guided revenue in the range of $38.2B - $39.4B for the period.
Compared to prior guidance, Amgen raised its EPS outlook from a previous range of $21.7 - $23.1. On the revenue side, the company raised its revenue forecast from a prior range of $37.1B - $38.5B.
Amgen has issued 16 guidance updates between November 3, 2022 and August 4, 2026. During this period, the company raised its outlook 7 times, reflecting management's growing confidence in business performance.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.77 | $5.60 | $4.76 | $4.75 |
| Actual | — | $6.29 | $5.15 | $5.29 |
| Surprise | — | +12.3% | +8.19% | +11.4% |
| Revenue | ||||
| Estimate | $10.04B | $9.42B | $8.55B | $9.46B |
| Actual | — | $10.05B | $8.62B | $9.87B |
| Surprise | — | +6.67% | +0.79% | +4.25% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $5.76 | $5.51 | $6.51 |
| Revenue | |||
| Consensus | $10.26B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $6.29 | $5.60 | 12.3 % |
| Q1 | Apr 30, 2026 | $5.15 | $4.76 | 8.19 % |
| Q4 | Feb 3, 2026 | $5.29 | $4.75 | 11.4 % |
| Q3 | Nov 4, 2025 | $5.64 | $5.01 | 12.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $10.05B | $9.42B | 6.67 % |
| Q1 | Apr 30, 2026 | $8.62B | $8.55B | 0.79 % |
| Q4 | Feb 3, 2026 | $9.87B | $9.46B | 4.25 % |
| Q3 | Nov 4, 2025 | $9.56B | $8.96B | 6.71 % |
